Literature DB >> 3692601

Treatment of infections in patients with cystic fibrosis.

M I Marks.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3692601     DOI： 10.1007/bf01647727

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  A placebo-controlled trial of cephalexin therapy in the ambulatory management of patients with cystic fibrosis.

Authors:  V A Loening-Baucke; E Mischler; M G Myers
Journal:  J Pediatr       Date:  1979-10       Impact factor: 4.406

Review 2.  Pulmonary infections in patients with cystic fibrosis: where to now?

Authors:  M I Marks
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

Review 3.  High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.

Authors:  F Sörgel; U Stephan; H G Wiesemann; B Gottschalk; C Stehr; M Rey; H B Böwing; H C Dominick; M Geldmacher von Mallinckrodt
Journal:  Infection       Date:  1987       Impact factor: 3.553

4.  Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Authors:  A Bauernfeind; R M Bertele; K Harms; G Hörl; R Jungwirth; C Petermüller; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

5.  Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.

Authors:  A Bauernfeind; K Rotter; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Unusual mechanism of pathogenicity of Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  B Tümmler
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 7.  Why is Pseudomonas the colonizer and why does it persist?

Authors:  R Ramphal; S Vishwanath
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

8.  Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.

Authors:  B Przyklenk; A Bauernfeind; G Hörl; G Emminger
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

9.  Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.

Authors:  B U von Specht; G Strigl; W Ehret; W Brendel
Journal:  Infection       Date:  1987       Impact factor: 3.553

10.  Selective pressure of antistaphylococcal chemotherapeutics in favour of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  A Bauernfeind; G Emminger; G Hörl; B Lorbeer; B Przyklenk; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.